Synchron Brain Implant Targets 2026 Pivotal Trial for First FDA-Approved BCI

Synchron, the brain-computer interface company whose Stentrode implant reaches the brain through a blood vessel instead of open-skull surgery, is preparing a pivotal clinical trial in 2026 — the study it must clear before it can ask the U.S.